As part of IBEC's science education initiatives, this year we have been running the IMAB project, which aims to bring the latest advances in bioengineering in organ and tissue regeneration to the over-65s. The aim of the project, beyond being a dissemination activity, has been to gather their impressions and transmit them to the scientific ... Read more
Laboratories consume three to five times more energy and resources than standard office spaces, with significant environmental impacts from constant equipment operation and disposable plastic use. Against this background, the project ‘Sustainable Laboratories’ (NACH-LABS), a joint effort of the Hamburg University of Applied Sciences, the Technical University of Darmstadt, and IUTA e.V., the European School of Sustainability Science and ... Read more
Developability assessment of biologics and formulation of novel molecules Shahid Uddin, PhD, MBA, Senior Director of Drug Product, Formulation & Stability within the CMC department at Immunocore, UK It’s vital to ensure appropriate assessment of molecules at the early research phase is carried out to risk mitigate movement into the development phase. This ensures the best risk ... Read more
Nanomedicine to Tackle Unmet Medical Needs in CNS Disorders Sabina Quader, Innovation Center of NanoMedicine (iCONM), Kawasaki Institute of Industrial Promotion, Kawasaki, Kanagawa 210-0821 Japan The brain is undoubtedly the body's most essential and intricate organ, and brain disorders are closely tied to this intricacy. Categorized as "CNS diseases," a wide range of brain-related conditions - ... Read more
Semi-synthetic nucleosomes to stabilize and image enzyme-chromatin interactions Carlos Moreno Yruela, Researcher in Chemical Biology, EPFL, Switzerland Chromatin structure regulates gene expression and is tightly controlled by histone post-translational modifications. SIRT7 is a histone lysine deacylase found to maintain oncogenic gene expression profiles supporting tumor growth and metastasis. Interestingly, the activity of SIRT7 is fully ... Read more
Harnessing the power of stem cell therapy in an off-the-shelf nano-delivery platform for treating brain disorders Prof Marcelle Machluf, Faculty of Biotechnology and Food Engineering, Technion, Haifa, Israel Mesenchymal stem cells (MSCs) have gained the most attention in cell therapy, owing to their ability to traverse physiological barriers, and target different sites of inflammation including ... Read more
Advances in understanding and manipulating influenza A virus liquid inclusions Maria João Amorim, PhD, Group Leader, Cell Biology of Viral Infection Lab, Católica Biomedical Research Centre, Universidade Católica Portuguesa, and Instituto Gulbenkian de Ciência, Portugal Many viruses form biomolecular condensates de novo as part of their replication programmes. Influenza A virus is an important human pathogen ... Read more
Animal welfare VS human welfare: To what extent do we want to protect them? The use of experimental animals is widely accepted within the scientific community and although there are differences in regulations between countries, they all follow the guidelines set by the 3Rs: Replace, Reduce and Refine. This event will be held in Spanish. ... Read more
The second edition of the Emerging Leaders in Biomedicine Symposium will take place on September 26th, 2024 at the Vall d’Hebron Institute of Oncology. This exceptional event is a collaborative effort between: Vall d'Hebron Institute of Oncology (VHIO) Josep Carreras Leukaemia Research Institute Institute for Bioengineering of Catalonia (IBEC) Institute of Molecular Biology of Barcelona (IBMB) Centre ... Read more
Investigating therapeutic targeting to intercellular adhesion molecule 1 through epitope, isoform, and cross-reactivity selection Author: Marco Vigo, Targeted Therapeutics and Nanodevices and Nanobioengineering group Reading date: 26/09/2024 Reading time: 10:00 Reading place: Facultat de Medicina de la Universitat de Barcelona – Aula 4.1 If you want to join online, you can connect via Teams here. ... Read more